| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038013 Can be used for diagnosis, drug screening, clinical trial monitoring and the treatment of physiological disorders |
| 03/28/2002 | US20020038003 Novel antibody recognizing a small subset of human hematopoietic cells |
| 03/28/2002 | US20020037870 Method of inhibiting cancer cell growth using a vector expressing pRb2/p130 |
| 03/28/2002 | US20020037869 Human bad polypeptides, encoding nucleic acids and methods of use |
| 03/28/2002 | US20020037867 Administering into muscle of mammals |
| 03/28/2002 | US20020037852 Anticarcinogenic agents |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037847 Nucleic acids encoding kringle 1-5 region fragments of plasminogen |
| 03/28/2002 | US20020037836 Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders |
| 03/28/2002 | US20020037833 Administering botulinium toxin component coupled to substance P |
| 03/28/2002 | US20020037575 Recombinant virus vectors |
| 03/28/2002 | US20020037572 Novel mammalian secreted group III phospholipase A2 |
| 03/28/2002 | US20020037551 Polypeptide; for use in diagnosis and treatment of infections, anemia, nephritis, respiratory and cardiovascular disorders |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037522 Protein; for use in the prevention of antibiotic resistance in cancer therapy |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037292 Avian polynucleotide vaccine formula |
| 03/28/2002 | US20020037282 Universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 03/28/2002 | US20020037281 Methods of transducing neural cells using lentivirus vectors |
| 03/28/2002 | US20020037280 Useful for regulating transgene expression in cells such as tumor cells and therefore, for therapy of a variety of cancers |
| 03/28/2002 | US20020037279 Delivery of bioactive compounds to an organism |
| 03/28/2002 | US20020037278 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 03/28/2002 | US20020037274 Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10135996A1 Identifying metastatic tumor cells and screening for antitumor agents, comprises hybridization to specific cDNA sequences |
| 03/28/2002 | DE10106829A1 Arzneimittel mit einer für das RNA-bindende KOC-Protein kodierenden DNA-Sequenz, einem KOC-Protein oder einer DNA-Sequenz des KOC-Promotors Drugs with a gene encoding the RNA binding protein KOC-DNA sequence, a protein or KOC a DNA sequence of the promoter KOC |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | DE10028376A1 Epididymis-spezifische Proteine mit Fibronektin Typ II-Modulen Epididymis-specific proteins with fibronectin type II modules |
| 03/28/2002 | CA2423703A1 Use of a nucleic acid/pei complex |
| 03/28/2002 | CA2423093A1 Improved system for regulation of transgene expression |
| 03/28/2002 | CA2423091A1 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 03/28/2002 | CA2423082A1 Expression vectors containing hybrid ubiquitin promoters |
| 03/28/2002 | CA2423044A1 Induction of exon skipping in eukaryotic cells |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2422868A1 Control of nk cell function and survival by modulation of ship activity |
| 03/28/2002 | CA2422863A1 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 03/28/2002 | CA2422544A1 Conditionally replicating viral vectors and their use |
| 03/28/2002 | CA2422524A1 Pei: dna vector formulations for in vitro and in vivo gene delivery |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421864A1 Transduction of dendritic cells using adenoviral vectors |
| 03/28/2002 | CA2421576A1 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | CA2421249A1 21 human secreted proteins |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1191105A1 Gene delivery vectors provided with a tissue tropism for T-lymphocytes |
| 03/27/2002 | EP1191104A1 Gene delivery vehicles and use thereof in the preparation of a medicament and/or vaccine |
| 03/27/2002 | EP1191097A1 Induction of exon skipping in eukaryotic cells |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1190257A1 Early detection of flaviviruses using the ns1 glycoprotein |
| 03/27/2002 | EP1190249A2 Compounds and methods to enhance raav transduction |
| 03/27/2002 | EP1190099A1 Antisense modulation of pi3k p85 expression |
| 03/27/2002 | EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 03/27/2002 | EP1190085A2 Non-squamous epithelium-specific transcription |
| 03/27/2002 | EP1190084A1 Regulation system of expression using nuclear ppar receptors |
| 03/27/2002 | EP1190083A2 Dna constructs based on the eif4a gene promoter |
| 03/27/2002 | EP1190082A1 Method of inducing angiogenesis by micro-organs |
| 03/27/2002 | EP1190079A2 Control of gene expression in eukaryotic cells |
| 03/27/2002 | EP1190073A2 Control of gene expression |
| 03/27/2002 | EP1190065A2 Atp binding cassette transporter protein abc1 polypeptides |
| 03/27/2002 | EP1190063A1 Nucleic and proteinic acids corresponding to human gene abc1 |
| 03/27/2002 | EP1190061A1 Streptavidin expressed gene fusions and methods of use thereof |
| 03/27/2002 | EP1190059A1 Sgip peptides |
| 03/27/2002 | EP1190057A1 Cloning and expression of a novel 5-ht4 receptor |
| 03/27/2002 | EP1190056A1 Human cytokine receptor |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190054A1 Epithelial cell growth inhibitors |
| 03/27/2002 | EP1190053A2 Mammalian calcium channels and related probes, cell lines and methods |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1190049A1 Spliceosome protein and its use |
| 03/27/2002 | EP1190047A1 Antisense oligonucleotide modulating cyclin e gene expression and therapeutic uses thereof |
| 03/27/2002 | EP1190040A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 03/27/2002 | EP1189936A2 Use of eif4e binding agents in therapy |
| 03/27/2002 | EP1189918A1 Antisense modulation of integrin beta 3 expression |
| 03/27/2002 | EP1189917A1 48 human secreted proteins |
| 03/27/2002 | EP1189632A1 Pneumococcal surface protein combination vaccine |
| 03/27/2002 | EP1189631A1 Neurodegenerative disorder related gene |
| 03/27/2002 | EP1189626A1 Method for preventing tumoral growth |
| 03/27/2002 | EP1189611A1 Cancer therapy |
| 03/27/2002 | EP1077068B1 Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0998501B1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 03/27/2002 | EP0870018B1 Antitumour vector constructs and methods |
| 03/27/2002 | CN1342264A Heart abnormalities in vascular endothelial growth factor B(VEGF-B) deficient animals and methods relating to these heart abnormalities |
| 03/27/2002 | CN1342206A Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
| 03/27/2002 | CN1342165A Neurotrophic growth factor |
| 03/27/2002 | CN1342088A Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof |
| 03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
| 03/27/2002 | CN1341644A A novel polypeptide-human heterogeneous nuclear-nucleoprotein 32.01 and polynucleotide for coding said polypeptide |
| 03/27/2002 | CN1341453A Preparation method of cytokine transfection stroma cell construction functional diffusion chamber |
| 03/27/2002 | CN1341452A Equipment utilizing electric pulse to transfer gene |
| 03/26/2002 | US6362326 For therapy of bacterial, fungal, protozoan and viral infections, particularly infection caused by hiv-1 or hiv-2; pain; cancers; diabetes; obesity; anorexia and bulimia; asthma; parkinson's disease; both acute and congestive heart |
| 03/26/2002 | US6362322 Conversion of a watson-crick DNA to a hoogsteen-paired duplex |
| 03/26/2002 | US6362001 Establishing a culture of drosophila cells; transfecting with expressible class 1 mhc heavy chain gene linked to promoter; transfecting with an expressible .beta.-2 microglobulin gene and with assisting molecule gene, mixing with peptide |
| 03/26/2002 | US6361997 Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy |